Inactief instrument

Koers Cascadian Therapeutics Inc (USA) Nasdaq

Aandelen

Duur

Periode

Stijl

Cascadian Therapeutics Announces 2018 Outlook and Recent Progress	04-01-18
Cascadian Therapeutics Receives Pediatric Investigation Plan Waiver from the European Medicines Agency	02-01-18
Cascadian Therapeutics Added to the Nasdaq Biotechnology Index	13-12-17
Prolonged Progression-Free Survival Reinforces Tucatinib’s Potential for Patients with Advanced HER2+ Metastatic Breast Cancer	07-12-17
Cascadian Therapeutics Reports Third Quarter 2017 Financial Results	08-11-17

Sector

	Vaira. 1 jan.	Kapi.
REGENERON PHARMACEUTICALS, INC.	+8,96%	105 mld.
VERTEX PHARMACEUTICALS INCORPORATED	-1,43%	104 mld.
ARGENX SE	+4,40%	22,94 mld.
BIONTECH SE	-12,15%	22,34 mld.
GENMAB A/S	-4,36%	19,25 mld.
WUXI APPTEC CO., LTD.	-39,98%	17,08 mld.
BEIGENE, LTD.	-10,04%	16,96 mld.
SAREPTA THERAPEUTICS, INC.	+38,61%	12,63 mld.
VIKING THERAPEUTICS, INC.	+313,59%	8,49 mld.